Cyclohexylamine

Cyclohexylamine

SCHEMBL9979064

NC1CCCCC1.NC1CCCCC1.O=C(O)c1ccc(C(=O)NC2CCCCC2)c2c(C(=O)O)ccc(C(=O)NC3CCCCC3)c12

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.50
RAB9A P51151 5/20 0.50
ALDH1A1 P00352 4/20 0.50
LMNA P02545 3/20 0.50
GAA P10253 3/20 0.50
KDM4E B2RXH2 2/20 0.50
HTT P42858 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
HPGD P15428 2/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
GLA P06280 1/20 0.47
MAPK1 P28482 1/20 0.47
MAOA P21397 2/20 0.46
MAPT P10636 1/20 0.46
MAOB P27338 1/20 0.46
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclopentanamine SCHEMBL9979148 0.98 GAA (0.49) NPC1RAB9AALDH1A1LMNAGAA
SCHEMBL2159871 0.92 NPC1 (0.57) NPC1RAB9AALDH1A1LMNAGAA
SCHEMBL12021902 0.92 NPC1 (0.57) NPC1RAB9AALDH1A1LMNAGAA
SCHEMBL823228 0.92 NPC1 (0.57) NPC1RAB9AALDH1A1LMNAGAA
SCHEMBL12021895 0.91 GAA (0.55) NPC1RAB9AALDH1A1LMNAGAA
SCHEMBL5053780 0.91 GAA (0.55) NPC1RAB9AALDH1A1LMNAGAA
SCHEMBL822571 0.91 GAA (0.55) NPC1RAB9AALDH1A1LMNAGAA
SCHEMBL4930405 0.87 NPC1 (0.51) NPC1RAB9AALDH1A1LMNAGAA
SCHEMBL16351826 0.87 NPC1 (0.51) NPC1RAB9AALDH1A1LMNAGAA
SCHEMBL823149 0.87 NPC1 (0.51) NPC1RAB9AALDH1A1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8450726-B2 Articles containing coatings of amic acid salts EASTMAN KODAK COMPANY (US) 2013-05-28 US disclosed
US-8431433-B2 Methods of providing semiconductor layers from amic acid salts EASTMAN KODAK COMPANY (US) 2013-04-30 US disclosed
US-8404892-B2 Aromatic amic acid salts and compositions EASTMAN KODAK COMPANY (US) 2013-03-26 US disclosed
US-20110295010-A1 AROMATIC AMIC ACID SALTS AND COMPOSITIONS FPC INC. 2011-12-01 US disclosed
US-20110294257-A1 METHODS OF PROVIDING SEMICONDUCTOR LAYERS FROM AMIC ACID SALTS KODAK AMERICAS LTD. 2011-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110295010-A1 AROMATIC AMIC ACID SALTS AND COMPOSITIONS DDC, MYOC, TNNC1 NPC1 2760/4885RAB9A 1098/4885ALDH1A1 1563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.